anisodamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Qin, Z; Su, DF; Sun, Y; Xiang, K | 1 |
1 other study(ies) available for anisodamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.
Topics: Acupuncture; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Cytokines; Drugs, Chinese Herbal; Humans; Inflammation; Neuroimmunomodulation; Nicotine; SARS-CoV-2; Solanaceous Alkaloids; Vagus Nerve; Vagus Nerve Stimulation | 2020 |